Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Good
|
|
New words:
AAA, analogy, appeal, appointed, approach, ARB, authoritative, bid, BioPharma, clarified, classification, classified, collateralization, confusing, confusion, conserve, conserving, context, Cornerstone, corroboration, counterparty, CRtm, delist, delisted, delisting, depressing, discharge, distracted, doubt, duly, effectFSP, EITFNo, Engineering, exceeding, feet, fractional, furniture, goal, grace, identical, inactive, inclusion, incremental, index, inflation, inhibit, intangible, issuable, IssueNo, issuer, junior, literature, lowest, member, membership, merged, Microbia, morbidity, mortality, motivate, Neptune, nonfinancial, occupied, ofEITF, ofRegulation, orEITF, orFSP, Panel, paper, pathology, pediatric, percent, PERFOROMISTtm, poor, PositionNo, potent, Precision, pronouncement, pursing, quantity, quoted, ratio, rational, ready, reclassified, recoverability, refinance, regain, regaining, reinitiate, reintroducing, reintroduction, retrospectively, reverse, Rule, slower, split, square, standalone, stronger, surviving, thereunto, timetable, Transitory, unadjusted, undersigned, unobservable, Unregistered, vendor, waiver, WESTVIEW, wholly
Removed:
accident, accidental, achieved, advisor, allergic, allocation, amortize, APB, censure, computation, concentrate, contamination, convert, cycle, Dana, deemed, depreciation, devoted, disposing, employed, ending, enhance, extension, field, gradually, half, handle, Hilt, improved, injury, Interpretation, Investing, invoiced, lapsed, liable, maintained, moderate, modulation, opinion, organ, pharmacological, precautionary, prime, principally, Professionalsand, promulgated, radioactive, reached, registration, regulate, repayment, secure, short, space, spill, steroid, storage, Tanox, taxable, twelve, utility, utilized, vesting, vital, waste, Xolair
Filing tables
Filing exhibits
Related press release
CRTX similar filings
Filing view
External links
EXHIBIT 32.2
CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
PURSUANT TO RULE 13a-14(b)
OF THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350
PURSUANT TO RULE 13a-14(b)
OF THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350
In connection with the Quarterly Report on Form 10-Q of Critical Therapeutics, Inc. (the “Company”) for the period ended March 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Thomas P. Kelly, Chief Financial Officer and Senior Vice President of Finance and Corporate Development of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | ||
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: May 12, 2008
| /s/ Thomas P. Kelly | ||||
| Thomas P. Kelly | ||||
| Chief Financial Officer and Senior Vice President of Finance and Corporate Development (Principal Financial Officer) | ||||